Crago, Aimee

Publications

Sort by

Co-Author Network

selected publications

Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab: A Phase 2 Clinical Trial. JAMA oncology. 2020 Academic Article GET IT
Times cited: 131
PDLIM7 and CDH18 regulate the turnover of MDM2 during CDK4/6 inhibitor therapy-induced senescence. Oncogene. 2018 Academic Article GET IT
Times cited: 33
ATRX is a regulator of therapy induced senescence in human cells. Nature communications. 2017 Academic Article GET IT
Times cited: 57
Multimodality Management of Soft Tissue Tumors in the Extremity. The Surgical clinics of North America. 2016 Information Resource GET IT
Times cited: 9
Integrin-α10 Dependency Identifies RAC and RICTOR as Therapeutic Targets in High-Grade Myxofibrosarcoma. Cancer discovery. 2016 Academic Article GET IT
Times cited: 67
Liposarcoma: Multimodality Management and Future Targeted Therapies. Surgical oncology clinics of North America. 2016 Information Resource GET IT
Times cited: 106
Overall Survival and Response to Systemic Therapy in Metastatic Extrauterine Leiomyosarcoma. Sarcoma. 2016 Academic Article GET IT
Times cited: 10
The importance of surgical margins in retroperitoneal sarcoma. Journal of surgical oncology. 2015 Information Resource GET IT
Times cited: 28
A Phase Ib/II Study of Gemcitabine and Docetaxel in Combination With Pazopanib for the Neoadjuvant Treatment of Soft Tissue Sarcomas. The oncologist. 2015 Academic Article GET IT
Times cited: 23
Near universal detection of alterations in CTNNB1 and Wnt pathway regulators in desmoid-type fibromatosis by whole-exome sequencing and genomic analysis. Genes, chromosomes & cancer. 2015 Academic Article GET IT
Times cited: 139
Outcomes of Systemic Therapy for Patients with Metastatic Angiosarcoma. Oncology. 2015 Academic Article GET IT
Times cited: 44
Principles in Management of Soft Tissue Sarcoma. Advances in surgery. 2015 Information Resource GET IT
Times cited: 49
MDM2 turnover and expression of ATRX determine the choice between quiescence and senescence in response to CDK4 inhibition. Oncotarget. 2015 Academic Article GET IT
Times cited: 105
Soft tissue tumors of the trunk: management of local disease in the breast and chest and abdominal walls. Journal of surgical oncology. 2014 Information Resource GET IT
Times cited: 15
Extended surgical resection and histology in retroperitoneal sarcoma. Annals of surgical oncology. 2014 Editorial Article GET IT
Times cited: 18
Comparison of local recurrence with conventional and intensity-modulated radiation therapy for primary soft-tissue sarcomas of the extremity. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014 Academic Article GET IT
Times cited: 113
Drug synergy screen and network modeling in dedifferentiated liposarcoma identifies CDK4 and IGF1R as synergistic drug targets. Science signaling. 2013 Academic Article GET IT
Times cited: 76
A prognostic nomogram for prediction of recurrence in desmoid fibromatosis. Annals of surgery. 2013 Academic Article GET IT
Times cited: 207
Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2013 Academic Article GET IT
Times cited: 360
Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors. Nature genetics. 2013 Academic Article GET IT
Times cited: 474
Desmoid fibromatosis in children and adolescents: a conservative approach to management. Journal of pediatric surgery. 2013 Academic Article GET IT
Times cited: 20
Oncologic outcomes of sporadic, neurofibromatosis-associated, and radiation-induced malignant peripheral nerve sheath tumors. Annals of surgical oncology. 2012 Academic Article GET IT
Times cited: 107
The miR-17-92 cluster and its target THBS1 are differentially expressed in angiosarcomas dependent on MYC amplification. Genes, chromosomes & cancer. 2012 Academic Article GET IT
Times cited: 89
Copy number losses define subgroups of dedifferentiated liposarcoma with poor prognosis and genomic instability. Clinical cancer research : an official journal of the American Association for Cancer Research. 2012 Academic Article GET IT
Times cited: 61
Clinical and molecular approaches to well differentiated and dedifferentiated liposarcoma. Current opinion in oncology. 2011 Information Resource GET IT
Times cited: 202
Small RNA sequencing and functional characterization reveals MicroRNA-143 tumor suppressor activity in liposarcoma. Cancer research. 2011 Academic Article GET IT
Times cited: 104
ZIC1 overexpression is oncogenic in liposarcoma. Cancer research. 2010 Academic Article GET IT
Times cited: 41
Randomized clinical trials in breast cancer. Surgical oncology clinics of North America. 2010 Information Resource GET IT
Times cited: 7
Binding of extracellular matrix laminin to Escherichia coli expressing the Salmonella outer membrane proteins Rck and PagC. FEMS microbiology letters. 1999 Academic Article GET IT
Times cited: 29
Salmonella InvG forms a ring-like multimer that requires the InvH lipoprotein for outer membrane localization. Molecular microbiology. 1998 Academic Article GET IT
Times cited: 135
Monocyte chemoattractant activity of Ser195-->Ala active site mutant recombinant alpha-thrombin. Experimental cell research. 1995 Academic Article GET IT
Times cited: 20

more ...

less ...

Background

education and training

M.D., Harvard Medical School 2003
Ph.D., University of Cambridge (United Kingdom) 1999
B.S., Tulane University 1995

Contact

full name

Aimee Crago

VIVO Weill Cornell Medical College

Aimee Crago Associate Professor of Surgery

Publications

selected publications

Background

education and training

Contact

full name